At a glance
ClinicalIndex Comparison RecordN/ACompleted· 221,228 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Sequential Expansion of Comparative Effectiveness of Oral Anticoagulants: A Cohort Study
In Brief
An observational study for Atrial Fibrillation. Completed, enrolled 221,228 participants across 1 site.
Detailed Summary
This cohort study is the sequential expansion of the comparative effectiveness study of oral anticoagulants and plans to identify initiators of oral anticoagulants using electronic claims data from a commercial insurance database to quantify associations between anticoagulant choice (warfarin and dabigatran) and the occurrence of selected outcomes in patients with non-valvular atrial fibrillation at risk for stroke.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMar 2014
Enrollment StartMar 2014
Primary CompletionNov 2017
TodayJul 2026
First PostedMar 7, 2014
Enrollment StartMar 7, 2014
Primary CompletionNov 1, 2017
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 12.3 years ago